Showing results (281-290 of 1,479) with videos related to
Sort By:
Pageof 148
Human Psychopharmacology|February 6, 2020
Assessing the validity of eyelid parameters to detect impairment due to benzodiazepinesVanessa E Wilkinson, Melinda L Jackson, Justine Westlake, et al.Human Psychopharmacology|August 17, 2017
Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured reviewFleur M Howells, David G Kingdon, David S BaldwinHuman Psychopharmacology|January 13, 2018
Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorderSidney H Kennedy, Jean-Marie Grouin, Stéphanie Cadour, et al.Human Psychopharmacology|December 19, 2017
ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic settingGeorgios Papazisis, Antonios Goulas, Alexios Sarrigiannidis, et al.Human Psychopharmacology|May 28, 2022
Effects of solriamfetol on on-the-road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoeaFrederick Vinckenbosch, Jerryll Asin, Nicolaas de Vries, et al.Human Psychopharmacology|July 8, 2021
Co-ingestion of prescription drugs and alcohol in US adults aged 50 years or olderTy S Schepis, Jason A Ford, Sean Esteban McCabeHuman Psychopharmacology|April 3, 2020
Effect of venlafaxine dosage, valproic acid concentration, sex, and age on steady state dose-corrected concentrations of venlafaxine and O-desmethylvenlafaxine: A retrospective analysis of therapeutic drug monitoring data in a Chinese populationZhan-Zhang Wang, Shu-Hua Deng, Hao-Yang Lu, et al.Human Psychopharmacology|September 18, 2020
Differential effects of different antipsychotic drugs on cognitive function in patients with chronic schizophreniaRui Dong, Lian Yuan, Yong Yang, et al.Human Psychopharmacology|November 17, 2021
Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic designLisanne M Geers, Taichi Ochi, Natalya M Vyalova, et al.Human Psychopharmacology|January 7, 2022
Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorderVarsha Ramesh, Vettriselvi Venkatesan, Balakrishnan RamasamyPageof 148